The fold of α-synuclein fibrils

The aggregation of proteins into amyloid fibrils is associated with several neurodegenerative diseases. In Parkinson's disease it is believed that the aggregation of α-synuclein (α-syn) from monomers by intermediates into amyloid fibrils is the toxic disease-causative mechanism. Here, we studied the structure of α-syn in its amyloid state by using various biophysical approaches. Quenched hydrogen/deuterium exchange NMR spectroscopy identified five β-strands within the fibril core comprising residues 35–96 and solid-state NMR data from amyloid fibrils comprising the fibril core residues 30–110 confirmed the presence of β-sheet secondary structure. The data suggest that β1-strand interacts with β2, β2 with β3, β3 with β4, and β4 with β5. High-resolution cryoelectron microscopy revealed the protofilament boundaries of ≈2 × 3.5 nm. Based on the combination of these data and published structural studies, a fold of α-syn in the fibrils is proposed and discussed.

[1]  K. Takegoshi,et al.  Indirect high-resolution observation of 14N NMR in rotating solids. , 2001, Journal of the American Chemical Society.

[2]  B. Meier,et al.  Adiabatic dipolar recoupling in solid-state NMR: the DREAM scheme. , 2001, Journal of magnetic resonance.

[3]  L. Serpell,et al.  Synuclein proteins of the pufferfish Fugu rubripes: sequences and functional characterization. , 2006, Biochemistry.

[4]  A. Brice,et al.  Alpha-synuclein and Parkinson's disease , 2000, Cellular and Molecular Life Sciences CMLS.

[5]  Makoto Hashimoto,et al.  Transgenic models of alpha-synuclein pathology: past, present, and future. , 2003, Annals of the New York Academy of Sciences.

[6]  P. Lansbury,et al.  Accelerated Oligomerization by Parkinson's Disease Linked α‐Synuclein Mutants , 2000 .

[7]  Michele Vendruscolo,et al.  Prediction of "aggregation-prone" and "aggregation-susceptible" regions in proteins associated with neurodegenerative diseases. , 2005, Journal of molecular biology.

[8]  David Eisenberg,et al.  Recent atomic models of amyloid fibril structure. , 2006, Current opinion in structural biology.

[9]  C. Dobson,et al.  Mapping long-range interactions in alpha-synuclein using spin-label NMR and ensemble molecular dynamics simulations. , 2005, Journal of the American Chemical Society.

[10]  Robert A. Grothe,et al.  Structure of the cross-β spine of amyloid-like fibrils , 2005, Nature.

[11]  Michel Goedert,et al.  Alpha-synuclein and neurodegenerative diseases , 2001, Nature Reviews Neuroscience.

[12]  J Q Trojanowski,et al.  A Hydrophobic Stretch of 12 Amino Acid Residues in the Middle of α-Synuclein Is Essential for Filament Assembly* , 2001, The Journal of Biological Chemistry.

[13]  M. Blackledge,et al.  Defining long-range order and local disorder in native alpha-synuclein using residual dipolar couplings. , 2005, Journal of the American Chemical Society.

[14]  Ted M. Dawson,et al.  Animal Models of PD Pieces of the Same Puzzle? , 2002, Neuron.

[15]  L. Regan,et al.  A general model for amyloid fibril assembly based on morphological studies using atomic force microscopy. , 2003, Biophysical journal.

[16]  P. Lansbury,et al.  Protofibrils, pores, fibrils, and neurodegeneration: separating the responsible protein aggregates from the innocent bystanders. , 2003, Annual review of neuroscience.

[17]  P. Lansbury,et al.  Accelerated oligomerization by Parkinson's disease linked alpha-synuclein mutants. , 2000, Annals of the New York Academy of Sciences.

[18]  S. Becker,et al.  Molecular-level secondary structure, polymorphism, and dynamics of full-length alpha-synuclein fibrils studied by solid-state NMR. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[19]  S. Lindquist,et al.  α-Synuclein Blocks ER-Golgi Traffic and Rab1 Rescues Neuron Loss in Parkinson's Models , 2006, Science.

[20]  Jeannie Chen,et al.  Investigation of α-Synuclein Fibril Structure by Site-directed Spin Labeling* , 2007, Journal of Biological Chemistry.

[21]  Sebastian Doniach,et al.  Biophysical Properties of the Synucleins and Their Propensities to Fibrillate , 2002, The Journal of Biological Chemistry.

[22]  B. Meier,et al.  INADEQUATE-CR experiments in the solid state. , 1999, Journal of magnetic resonance.

[23]  J. Gibrat,et al.  GOR method for predicting protein secondary structure from amino acid sequence. , 1996, Methods in enzymology.

[24]  T. Iwatsubo,et al.  Biochemical characterization of the core structure of alpha-synuclein filaments. , 2002, The Journal of biological chemistry.

[25]  B. Meier,et al.  Adiabatic passage Hartmann-Hahn cross polarization in NMR under magic angle sample spinning , 1995 .

[26]  E. Masliah,et al.  beta-Synuclein inhibits alpha-synuclein aggregation: a possible role as an anti-parkinsonian factor. , 2001, Neuron.

[27]  Thorsten Lührs,et al.  Correlation of structural elements and infectivity of the HET-s prion , 2005, Nature.

[28]  A Dürr,et al.  Causal relation between alpha-synuclein gene duplication and familial Parkinson's disease. , 2004, Lancet.

[29]  D. Eliezer,et al.  Conformational properties of alpha-synuclein in its free and lipid-associated states. , 2001, Journal of molecular biology.

[30]  R. Riek,et al.  3D structure of Alzheimer's amyloid-beta(1-42) fibrils. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[31]  Susan E Daniel,et al.  Characterisation of isolated α-synuclein filaments from substantia nigra of Parkinson's disease brain , 2000, Neuroscience Letters.

[32]  B. Meier,et al.  Polarization-transfer methods in solid-state magic-angle-spinning NMR: adiabatic CN pulse sequences. , 2004, Chemphyschem : a European journal of chemical physics and physical chemistry.

[33]  Gerd Buntkowsky,et al.  Solid State NMR Reveals a pH-dependent Antiparallel β-Sheet Registry in Fibrils Formed by a β-Amyloid Peptide , 2004 .

[34]  T. Nagatsu.  [Biochemistry of Parkinson's disease]. , 1988, Seikagaku. The Journal of Japanese Biochemical Society.

[35]  Seung-Jae Lee,et al.  Characterization of cytoplasmic alpha-synuclein aggregates. Fibril formation is tightly linked to the inclusion-forming process in cells. , 2002, The Journal of biological chemistry.

[36]  Gerd Krause,et al.  General structural motifs of amyloid protofilaments , 2006, Proceedings of the National Academy of Sciences.

[37]  M. Hoshino,et al.  Mapping the core of the beta(2)-microglobulin amyloid fibril by H/D exchange. , 2002, Nature structural biology.

[38]  A. Linstedt.  Faculty Opinions recommendation of Alpha-synuclein blocks ER-Golgi traffic and Rab1 rescues neuron loss in Parkinson's models. , 2006 .

[39]  R. Crowther,et al.  Characterisation of isolated alpha-synuclein filaments from substantia nigra of Parkinson's disease brain. , 2000, Neuroscience letters.

[40]  J. Trojanowski,et al.  Mechanisms of Parkinson's Disease Linked to Pathological α-Synuclein: New Targets for Drug Discovery , 2006, Neuron.

[41]  Peter T Lansbury,et al.  Beta-synuclein inhibits formation of alpha-synuclein protofibrils: a possible therapeutic strategy against Parkinson's disease. , 2003, Biochemistry.

[42]  R. Riek,et al.  3D structure of Alzheimer's amyloid-β(1–42) fibrils , 2005 .

[43]  Y. Yoo,et al.  Orphan Nuclear Receptor Nur77 Translocates to Mitochondria in the Early Phase of Apoptosis Induced by Synthetic Chenodeoxycholic Acid Derivatives in Human Stomach Cancer Cell Line SNU‐1 , 2003, Annals of the New York Academy of Sciences.

[44]  T. Iwatsubo,et al.  Biochemical Characterization of the Core Structure of α-Synuclein Filaments* , 2002, The Journal of Biological Chemistry.

[45]  J. George,et al.  The synucleins , 2001, Genome Biology.

[46]  Makoto Hashimoto,et al.  β-Synuclein Inhibits α-Synuclein Aggregation A Possible Role as an Anti-Parkinsonian Factor , 2001, Neuron.

[47]  David Eisenberg,et al.  Structural models of amyloid-like fibrils. , 2006, Advances in protein chemistry.

[48]  B. Meier,et al.  Efficient N-15-C-13 polarization transfer by adiabatic-passage Hartmann-Hahn cross polarization , 1996 .

[49]  L. Serpell,et al.  Fiber diffraction of synthetic alpha-synuclein filaments shows amyloid-like cross-beta conformation. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[50]  Makoto Hashimoto,et al.  Transgenic Models of α‐Synuclein Pathology , 2003 .

[51]  Ernst,et al.  Spin diffusion in resolved solid-state NMR spectra. , 1985, Physical review. B, Condensed matter.

[52]  V. Lee,et al.  Alpha-synuclein: normal function and role in neurodegenerative diseases. , 2004, Current topics in developmental biology.

[53]  Diego Guidolin,et al.  α‐Synuclein and Parkinson's disease , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[54]  V. Uversky,et al.  Effect of familial Parkinson's disease point mutations A30P and A53T on the structural properties, aggregation, and fibrillation of human alpha-synuclein. , 2001, Biochemistry.

[55]  A Dürr,et al.  Causal relation between α-synuclein locus duplication as a cause of familial Parkinson's disease , 2004, The Lancet.

[56]  Ralf Langen,et al.  Structural Organization of α-Synuclein Fibrils Studied by Site-directed Spin Labeling* , 2003, Journal of Biological Chemistry.

[57]  W. Bender,et al.  A Drosophila model of Parkinson's disease , 2000, Nature.

[58]  K. Iwata,et al.  3D structure of amyloid protofilaments of β2-microglobulin fragment probed by solid-state NMR , 2006, Proceedings of the National Academy of Sciences.

[59]  Jeannie Chen,et al.  Investigation of alpha-synuclein fibril structure by site-directed spin labeling. , 2007, The Journal of biological chemistry.

[60]  B. Meier,et al.  Methods for sequential resonance assignment in solid, uniformly 13C, 15N labelled peptides: Quantification and application to antamanide , 2001, Journal of biomolecular NMR.

[61]  L. Golbe.  Alpha-synuclein and Parkinson's disease. , 2003, Advances in neurology.

[62]  Patrik Brundin,et al.  Pathogenesis of Parkinson's disease: dopamine, vesicles and alpha-synuclein. , 2002, Nature reviews. Neuroscience.

[63]  P. Lansbury,et al.  Fibrils formed in vitro from alpha-synuclein and two mutant forms linked to Parkinson's disease are typical amyloid. , 2000, Biochemistry.